Open original FDA record ↗Recall record
- FDA identifier
- Z-0811-05
- Company in FDA record
- Heartport, Inc.
- FDA classification date
- May 10, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Guidewire is protruding through the film portion of the packages which compromises the sterility of the device.
Source facts
- Action
- The recall was initiated on 4/8/2005. All accounts were phoned so as to cancel any scheduled surgical procedures that rely on these devices. Also the firm formally notified the hospitals in writing via letters to the Director of Material Managment, Director of OR, as well as the Director of the Cardiovascular Suite. Letters were sent via certified mail.
- Initiated
- 2005-04-12
- Root cause
- Other
- Terminated
- 2005-10-31
- Distribution
- The devices were distributed to 70 consignees in the US and 43 international customers. The devices are distributed directly to customers (hospitals, clinics) in the US, Belgium, Canada, Czech Republic, France, Germany, Great Britain, Hungary, Israel, Italy, Netherlands, and Spain. There are no government accounts.
- Recall number
- Z-0811-05
- Recall status
- Terminated
- CDRH record ID
- 38562
- FDA classified
- 2005-05-10
- Recall event number
- 31819